Susan E. Cellitti
6Patents
2h-index
25Co-inventors
47Inventor score
Filing activity: Oct 23, 2009 → Jun 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9458214B2 | Dual function fibroblast growth factor 21 proteins | Chemistry; Metallurgy | 8 | Active |
| US10669323B2 | Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins | Chemistry; Metallurgy | 3 | Active |
| US9624520B2 | Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues | Chemistry; Metallurgy | 1 | Active |
| US12171839B2 | Antibody drug conjugates for ablating hematopoietic stem cells | Chemistry; Metallurgy | 0 | Active |
| US11357864B2 | Antibody drug conjugates for ablating hematopoietic stem cells | Chemistry; Metallurgy | 0 | Active |
| US8785151B2 | Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.